Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.
To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030-/249.html
The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and encapsulation technologies market has been analyzed across the following segments:
Type of licensing deal payment
Upfront payment
Milestone payment
Therapeutic area
Metabolic disorder
Neurological disorder
Ophthalmic disorder
Oncological disorder
Target disease indication
Ataxia telangiectasia
Breast cancer
Diabetes
Glaucoma
Head and neck cancer
Macular telangectasia
Pancreatic cancer
Parkinson's disease
Retinitis pigmentosa
Type of encapsulation material used
Alginate-based microcapsule
Cellulose hydrogel
Medical-grade plastic
Red blood cell
Key geographical region
North America
Europe
Asia-Pacific and rest of the world
The Cell Encapsulation: Focus on Therapeutics and Technologiesv, 2019-2030 report features the following companies, which we identified to be key players in this domain:
- ALTuCELL
- Azellon Cell Therapeutics
- Beta-Cell
- Betalin Therapeutics
- CellProtect Biotechnology
- Diatranz Otsuka
- Encellin
- EryDel
- Gloriana Therapeutics
- Living Cell Technologies
- MaxiVAX
- Neurotech Pharmaceuticals
- PharmaCyte Biotech
- Semma Therapeutics
- Sernova
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Current Market Landscape
5. Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles
6. Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles
7. Patent Analysis
8. Clinical Trial Analysis
9. Recent Partnerships
10. Funding and Investment Analysis
11. Grant Analysis
12. Potential Strategic Partners
13. Market Forecast
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
